Uvax Bio Appoints Kevin O'Neill as Interim Chief Executive Officer
Uvax Bio, LLC, ("Uvax” or "the Company”) a privately held, clinical-stage vaccine company utilizing rational and computational biology to design and deliver novel 1c-SApNP ® protein-based vaccines, today announced the appointment of Chief Business Officer Kevin O'Neill to Interim Chief Executive Officer (CEO).
Fogo de Chão Announces Appointment of New Chief Marketing Officer
Georgeanne succeeds Janet Gieselman who spent more than a decade with Fogo, six years of which she served as Chief Marketing Officer. Janet’s retirement was announced December 2024 following a distinguished career spanning over 25 years in the restaurant industry.
One month into his new position, Stéphane de La Faverie, president and chief executive officer of the Estée Lauder Cos., is ...
With West Indies cricket standing at a pivotal crossroads, Dehring’s arrival signals a commitment to renewal and progress. As ...
Ford Motor named Marin Gjaja as chief strategy officer, part of a broader leadership change. Gjaja joined the automotive ...
Bowes joined Estée Lauder in 2015 and has led global talent acquisition and talent management during his career there. Before joining Estée Lauder, he was a managing director of executive search at ...
Ghana-focused player confirmed appointment of Richard Miller on Tuesday as interim chief executive and chief financial ...
CONCORD, Ontario, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Highly regarded executive, Germán Piderit, has joined Wyse Meter Solutions Inc. (“Wyse”) as Chief Operating Officer, effective January 27, 2025.
Contract chipmaker GlobalFoundries has appointed Tim Breen as its chief executive officer, the company said on Wednesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback